Cargando…
Development of an oncolytic Herpes Simplex Virus using a tumor-specific HIF-responsive promoter
We exploited the differential activation of hypoxia-inducible factor (HIF)-dependent gene expression in tumors versus normal tissue for the design of a targeted oncolytic Herpes simplex virus type-1 (HSV-1). A gene that is essential for viral replication, ICP4, was placed under the regulation of a H...
Autores principales: | Longo, Sharon L., Griffith, Christopher, Glass, Aaron, Shillitoe, Edward J., Post, Dawn E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021095/ https://www.ncbi.nlm.nih.gov/pubmed/20930860 http://dx.doi.org/10.1038/cgt.2010.62 |
Ejemplares similares
-
Oncolytic herpes simplex virus and immunotherapy
por: Ma, Wenqing, et al.
Publicado: (2018) -
Second-generation HIF-activated oncolytic adenoviruses with improved replication, oncolytic, and anti-tumor efficacy
por: Cherry, Tiffani, et al.
Publicado: (2010) -
Retargeting Strategies for Oncolytic Herpes Simplex Viruses
por: Campadelli-Fiume, Gabriella, et al.
Publicado: (2016) -
Replication and Spread of Oncolytic Herpes Simplex Virus in Solid Tumors
por: Hong, Bangxing, et al.
Publicado: (2022) -
Oncolytic Herpes Simplex Virus-Based Therapies for Cancer
por: Aldrak, Norah, et al.
Publicado: (2021)